| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 21.68B | 11.26B | 10.66B | -7.94B | 16.25B |
| Gross Profit | 21.68B | 11.26B | 15.15B | -7.94B | 16.25B |
| EBITDA | 1.77B | 754.00M | 1.27B | -2.58B | 1.09B |
| Net Income | 302.00M | -360.00M | 297.00M | -1.63B | 83.00M |
Balance Sheet | |||||
| Total Assets | 190.60B | 184.22B | 189.62B | 190.37B | 217.47B |
| Cash, Cash Equivalents and Short-Term Investments | 4.90B | 4.84B | 5.59B | 4.88B | 6.91B |
| Total Debt | 6.91B | 6.91B | 8.03B | 7.96B | 9.34B |
| Total Liabilities | 187.41B | 180.90B | 185.10B | 187.54B | 212.12B |
| Stockholders Equity | 3.14B | 3.28B | 4.04B | 2.78B | 5.30B |
Cash Flow | |||||
| Free Cash Flow | 612.00M | 388.00M | 1.52B | -1.27B | 352.00M |
| Operating Cash Flow | 787.00M | 677.00M | 2.02B | -694.00M | 1.12B |
| Investing Cash Flow | -152.00M | 152.00M | -603.00M | -368.00M | -466.00M |
| Financing Cash Flow | -531.00M | -1.14B | -680.00M | -1.01B | -501.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £4.30B | 5.71 | 41.35% | 5.93% | 4.28% | 5.18% | |
77 Outperform | £3.48B | 9.24 | 6.50% | 7.21% | -7.11% | 0.45% | |
76 Outperform | £8.97B | 11.95 | 12.35% | 5.37% | 4.78% | -4.86% | |
74 Outperform | £2.40B | 8.36 | 8.35% | 3.40% | -28.04% | -102.43% | |
70 Outperform | £2.09B | 17.89 | 4.75% | 4.91% | 14.05% | -3.07% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
52 Neutral | £6.76B | 22.80 | 9.49% | 7.09% | 9.86% | -134.41% |